Stock A217330 CYTOGEN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Cytogen, Inc.

Equities

A217330

KR7217330000

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-04 pm EDT 		5-day change 1st Jan Change
9,770 KRW +4.16% Intraday chart for Cytogen, Inc. -1.81% -27.74%
Mar. 20 Cytogen, Inc. announced that it has received KRW 9.8 billion in funding from NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd. and other investors CI
Mar. 18 Cytogen, Inc. announced that it expects to receive KRW 9.8 billion in funding from NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd. and other investors CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cytogen, Inc. announced that it has received KRW 9.8 billion in funding from NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd. and other investors
CI
Cytogen, Inc. announced that it expects to receive KRW 9.8 billion in funding from NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd. and other investors
CI
Cytogen, Inc. announced that it has received KRW 55.49999 billion in funding from CanDx Holdings Limited
CI
Cytogen, Inc. announced that it expects to receive KRW 99.999821616 billion in funding from Candx Holdings Limited
CI
Candx Holdings Limited agreed to acquire a 31.96% stake in Cytogen, Inc. from Jeon Byung Hee and others for KRW 110 billion
CI
Cytogen, Inc. announces tranche update
CI
Cytogen Raising KRW10 Billion to Finance Operations
MT
Cytogen, Inc. announced that it expects to receive KRW 69.99999 billion in funding from Excelsior Capital Korea Limited
CI
Cytogen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Cytogen, Inc.(KOSDAQ:A217330) added to S&P Global BMI Index
CI
TSD Life Sciences Co.,Ltd. announced that it has received KRW 2.9999853 billion in funding from Cytogen, Inc.
CI
TSD Life Sciences Co.,Ltd. announced that it has received KRW 2.9999853 billion in funding from Cytogen, Inc.
CI
Cytogen, Inc. announced that it has received KRW 30 billion in funding
CI
Cytogen, Inc. announced that it expects to receive KRW 30 billion in funding
CI
TSD Life Sciences Co.,Ltd. announced that it expects to receive KRW 2.9999853 billion in funding from Cytogen, Inc.
CI
Cytogen, Inc. announced that it has received KRW 10 billion in funding
CI
Cytogen, Inc. announced that it expects to receive KRW 10 billion in funding
CI
Well Marker Bio Co., Ltd. announced that it has received KRW 18 billion in funding from a group of investors
CI
Cytogen, Inc. has completed an IPO in the amount of KRW 20.4 billion.
CI
Cytogen, Inc. has filed an IPO.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A217330 Stock
  4. News Cytogen, Inc.